Prologue Journal

An Alzheimer’s Advance, Not a Cure-All

• prologu5
• 06/09/202406/09/2024

Wall Street Journal

Donanemab promises progress. The FDA shouldn’t hold out for perfection.

https://www.wsj.com/articles/an-alzheimers-advance-not-a-cure-all-donanemab-drug-fda-24ab4455